UTW-21095-52840
2 vaccinations
1 coded response
21 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 275 / NC
- Registered
- 2021-11-12
- Relationship
- Child or adolescent in my care
- Guardian
- SYN-29415-53751
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-12
Registered in v-safe
-
2021-11-12
Dose 1 — Pfizer-BioNTech
- 2021-11-12
- 2021-11-13
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-26
- 2021-12-10
-
2021-12-18
Survey response — day 35, dose 1, dependentMedDRA: Loss of personal independence in daily activities, Pyrexia, Vomiting — Feeling: Good · Be unable to work or attend schoolFree text: One sick day. Threw up and had a low grade fever for less than 24 hours. Stayed home from school for one day. Felt better quickly.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Dose 2 — Pfizer-BioNTech
- 2021-12-24
- 2021-12-26
- 2021-12-29
- 2022-01-05
- 2022-01-10
- 2022-01-19
- 2022-01-26
- 2022-01-31
- 2022-03-21
- 2022-06-22
- 2022-12-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-12 | Pfizer-BioNTech | No |
| 2 | 2021-12-20 | Pfizer-BioNTech | No |
Free text
Release 10 — day 35, dose 1, dependent
Symptoms: One sick day. Threw up and had a low grade fever for less than 24 hours. Stayed home from school for one day. Felt better quickly.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Loss of personal independence in daily activities | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release